Exscientia PLC (EXAI)
4.67
-0.42
(-8.25%)
USD |
NASDAQ |
May 03, 16:00
4.67
0.00 (0.00%)
After-Hours: 20:00
Exscientia Price to Book Value: 1.302 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.302 |
| May 02, 2024 | 1.420 |
| May 01, 2024 | 1.433 |
| April 30, 2024 | 1.380 |
| April 29, 2024 | 1.288 |
| April 26, 2024 | 1.124 |
| April 25, 2024 | 1.113 |
| April 24, 2024 | 1.152 |
| April 23, 2024 | 1.222 |
| April 22, 2024 | 1.185 |
| April 19, 2024 | 1.182 |
| April 18, 2024 | 1.216 |
| April 17, 2024 | 1.205 |
| April 16, 2024 | 1.185 |
| April 15, 2024 | 1.216 |
| April 12, 2024 | 1.298 |
| April 11, 2024 | 1.369 |
| April 10, 2024 | 1.323 |
| April 09, 2024 | 1.369 |
| April 08, 2024 | 1.382 |
| April 05, 2024 | 1.347 |
| April 04, 2024 | 1.383 |
| April 03, 2024 | 1.361 |
| April 02, 2024 | 1.449 |
| April 01, 2024 | 1.511 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.592 |
| March 27, 2024 | 1.609 |
| March 26, 2024 | 1.598 |
| March 25, 2024 | 1.653 |
| March 22, 2024 | 1.687 |
| March 21, 2024 | 1.709 |
| March 20, 2024 | 1.909 |
| March 19, 2024 | 1.734 |
| March 18, 2024 | 1.776 |
| March 15, 2024 | 1.837 |
| March 14, 2024 | 1.851 |
| March 13, 2024 | 1.887 |
| March 12, 2024 | 1.675 |
| March 11, 2024 | 1.539 |
| March 08, 2024 | 1.475 |
| March 07, 2024 | 1.511 |
| March 06, 2024 | 1.508 |
| March 05, 2024 | 1.634 |
| March 04, 2024 | 1.673 |
| March 01, 2024 | 1.815 |
| February 29, 2024 | 1.845 |
| February 28, 2024 | 1.864 |
| February 27, 2024 | 1.975 |
| February 26, 2024 | 1.900 |
| February 23, 2024 | 1.825 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8828
Minimum
Dec 27 2022
10.22
Maximum
Oct 01 2021
2.321
Average
1.662
Median
May 30 2023
Price to Book Value Benchmarks
| AstraZeneca PLC | 6.322 |
| Biodexa Pharmaceuticals Plc | 0.8683 |
| Adaptimmune Therapeutics PLC | 7.434 |
| Verona Pharma PLC | 5.087 |
| NuCana PLC | 0.446 |
Price to Book Value Related Metrics
| PS Ratio | 22.47 |
| PEG Ratio | -0.1194 |
| Price | 4.67 |
| Earnings Yield | -31.58% |
| Market Cap | 590.17M |
| PEGY Ratio | -0.1194 |